论文部分内容阅读
【目的】解决临床上血小板输注无效的途径 ,改善血小板输注效果。【方法】选择淋巴细胞毒试验 (LCT)阳性 ,血小板输注无效的患者 2 0例 ,给予作补体依赖交叉试验 (CDC) ,从随意献血者中选出配型相合的血小板输注。【结果】所有患者从血小板输注无效转为有效 ,LCT阳性率也逐渐下降至消失 ,使血小板输注获得良好的效果。【结论】CDC交叉配型相合的血小板输注逆转了血小板输注无效的状况。
【Objective】 To solve the ineffective route of clinical platelet transfusion and to improve the effect of platelet transfusion. 【Methods】 Twenty patients with positive LCT and invalid platelet transfusion were enrolled in this study. Complement-dependent cross-over test (CDC) was performed to select suitable matched platelet transfusion from random blood donors. 【Results】 All patients turned invalid from platelet transfusion, and the positive rate of LCT gradually decreased to disappear, resulting in a good effect of platelet transfusion. 【Conclusion】 CDC crossmatching combined platelet transfusion reverses the ineffective condition of platelet transfusion.